Chihiro Yamamoto   Daisuke Minakata   Shunsuke Koyama   Kaoru Sekiguchi   Yuta Fukui   Rui Murahashi   Hirotomo Nakashima   Sae Matsuoka   Takashi Ikeda   Shin-Ichiro Kawaguchi   Yumiko Toda   Shoko Ito   Takashi Nagayama   Kento Umino   Hirofumi Nakano   Kaoru Morita   Ryoko Yamasaki   Masahiro Ashizawa   Masuzu Ueda   Kaoru Hatano   Kazuya Sato   Ken Ohmine   Shin-Ichiro Fujiwara   Yoshinobu Kanda   
Blood 140(6) 594-607 2022年8月
Triplet regimens such as lenalidomide, bortezomib, and dexamethasone (RVd) or thalidomide, bortezomib, and dexamethasone (VTd) are standard induction therapies for transplant-eligible newly diagnosed multiple myeloma (NDMM) patients. The addition ...